# Tailored Drug Titration Using Artificial Intelligence

> **NCT04223934** · NA · COMPLETED · sponsor: **Optima Integrated Health** · enrollment: 164 (actual)

## Conditions studied

- Hypertension

## Interventions

- **OTHER:** optima4BP

## Key facts

- **NCT ID:** NCT04223934
- **Lead sponsor:** Optima Integrated Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-18
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-06-27
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04223934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04223934, "Tailored Drug Titration Using Artificial Intelligence". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04223934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*